Balance Sheet Components

Certain balance sheet components are as follows:



	October 25,		January 25,
	2015		2015
Inventories:	(In millions)
Raw materials	$	117	$	157
Work in-process	91		92
Finished goods	217		234
Total inventories	$	425	$	483

At October 25, 2015, we had outstanding inventory purchase obligations totaling $442 million.



	October 25,		January 25,
	2015		2015
Accrued and Other Current Liabilities:	(In millions)
Unearned revenue (1)	$	229	$	296
Customer related liabilities (2)	151		143
Accrued payroll and related expenses	98		112
Professional service fees	24		17
Accrued restructuring and other charges (3)	15		—
Warranty accrual (4)	13		8
Taxes payable	7		3
Coupon interest on Notes	6		3
Facilities related liabilities	1		8
Other	16		13
Total accrued and other current liabilities	$	560	$	603


(1)	Unearned revenue primarily includes deferred revenue.


(2)	Customer related liabilities primarily includes accrued customer programs. Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended January 25, 2015, for a discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates.


(3)	Please refer to Note 15 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the accrued restructuring and other charges.


(4)	Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the warranty accrual.



	October 25,		January 25,
	2015		2015
Other Long-Term Liabilities:	(In millions)
Deferred income tax liability	$	325	$	232
Income taxes payable	76		121
Asset retirement obligation	7		7
Interest rate swap (1)	3		—
Deferred revenue (2)	1		108
Other	25		21
Total other long-term liabilities	$	437	$	489


(1)	Please refer to Note 9 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.

(2) Consists primarily of consideration received in advance of our performance obligations under the patent cross licensing agreement that we entered into with Intel Corporation in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the nine months ended October 25, 2015.